These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 18190639

  • 1. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
    Ramsey S, Lamb GW, Aitchison M, McMillan DC.
    BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639
    [Abstract] [Full Text] [Related]

  • 2. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.
    Lamb GW, McArdle PA, Ramsey S, McNichol AM, Edwards J, Aitchison M, McMillan DC.
    BJU Int; 2008 Sep; 102(6):756-61. PubMed ID: 18384626
    [Abstract] [Full Text] [Related]

  • 3. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L, Patard JJ, Chiodini P, Schips L, Ficarra V, Tostain J, de La Taille A, Altieri V, Lobel B, Zigeuner RE, Artibani W, Guillé F, Abbou CC, Salzano L, Gallo C.
    Cancer; 2005 Oct 01; 104(7):1362-71. PubMed ID: 16116599
    [Abstract] [Full Text] [Related]

  • 4. Prospective study of the role of inflammation in renal cancer.
    Qayyum T, McArdle PA, Lamb GW, Going JJ, Orange C, Seywright M, Horgan PG, Oades G, Aitchison MA, Edwards J.
    Urol Int; 2012 Oct 01; 88(3):277-81. PubMed ID: 22377628
    [Abstract] [Full Text] [Related]

  • 5. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
    Ficarra V, Novara G, Galfano A, Brunelli M, Cavalleri S, Martignoni G, Artibani W.
    BJU Int; 2009 Jan 01; 103(2):165-70. PubMed ID: 18782313
    [Abstract] [Full Text] [Related]

  • 6. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y, Saito K, Sakai K, Morimoto S.
    BJU Int; 2007 Jan 01; 99(1):77-80. PubMed ID: 16956357
    [Abstract] [Full Text] [Related]

  • 7. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.
    Ramsey S, Lamb GW, Aitchison M, McMillan DC.
    Br J Cancer; 2006 Oct 23; 95(8):1076-80. PubMed ID: 17003778
    [Abstract] [Full Text] [Related]

  • 8. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    Johnson TV, Abbasi A, Owen-Smith A, Young A, Ogan K, Pattaras J, Nieh P, Marshall FF, Master VA.
    J Urol; 2010 Feb 23; 183(2):480-5. PubMed ID: 20006861
    [Abstract] [Full Text] [Related]

  • 9. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K.
    J Urol; 2009 Mar 23; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.
    Lamb GW, Aitchison M, Ramsey S, Housley SL, McMillan DC.
    Br J Cancer; 2012 Jan 17; 106(2):279-83. PubMed ID: 22166802
    [Abstract] [Full Text] [Related]

  • 11. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z, Lv J, Ding K, Fu Q, Cao Q, Wang F.
    Int J Urol; 2009 Mar 17; 16(3):268-73. PubMed ID: 19087209
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer.
    Ramsey S, Lamb GW, Aitchison M, Graham J, McMillan DC.
    Cancer; 2007 Jan 15; 109(2):205-12. PubMed ID: 17149754
    [Abstract] [Full Text] [Related]

  • 13. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M, Saito K, Iimura Y, Fujii Y, Kawakami S, Kihara K.
    J Urol; 2008 Aug 15; 180(2):515-9. PubMed ID: 18550105
    [Abstract] [Full Text] [Related]

  • 14. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.
    J Urol; 2008 Oct 15; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [Abstract] [Full Text] [Related]

  • 15. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
    Bigot P, Lughezzani G, Karakiewicz P, Perrotte P, Rioux-Leclercq N, Catros-Quemener V, Bouet F, Moulinoux JP, Cipolla B, Patard JJ.
    J Urol; 2010 Feb 15; 183(2):486-91. PubMed ID: 20006872
    [Abstract] [Full Text] [Related]

  • 16. The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer.
    Ramsey S, Aitchison M, Graham J, McMillan DC.
    BJU Int; 2008 Jul 15; 102(1):125-9. PubMed ID: 18336617
    [Abstract] [Full Text] [Related]

  • 17. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
    McMillan DC, Canna K, McArdle CS.
    Br J Surg; 2003 Feb 15; 90(2):215-9. PubMed ID: 12555298
    [Abstract] [Full Text] [Related]

  • 18. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K, Asano T, Yoshii H, Satoh A, Sumitomo M, Hayakawa M.
    Int J Urol; 2006 Nov 15; 13(11):1365-70. PubMed ID: 17083384
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug 15; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
    Karakiewicz PI, Hutterer GC, Trinh QD, Jeldres C, Perrotte P, Gallina A, Tostain J, Patard JJ.
    Cancer; 2007 Sep 15; 110(6):1241-7. PubMed ID: 17639589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.